Mon, February 22, 2021

Martin Auster Maintained (UTHR) at Buy with Increased Target to $196 on, Feb 22nd, 2021

Martin Auster of Credit Suisse, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $169 to $196 on, Feb 22nd, 2021.

Martin has made no other calls on UTHR in the last 4 months.



There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 0 agree with Martin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Martin


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $275 on, Tuesday, February 16th, 2021
  • Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $195 on, Monday, February 1st, 2021